Skip to main content

Murugaiyan Gopal

NIH Rank #6928
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 11529091Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2024

Linked Award Amount
$1.7M
Full award amounts, FY2024
Award Records
5
Records listing this PI
Award-Linked Rank
#6,928
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Murugaiyan Gopal. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Murugaiyan Gopal as a PI. Multi-PI records show the full award amount for context.

  • 1R01DK138260-01R01
    Development of novel PD1 agonist therapeutic strategies for inflammatory bowel disease
    $463.7K
    award amount
  • 5R01AI151953-05R01
    The pathogenic role of miR-92a in the regulation of T helper cell responses in EAE and MS
    $422.2K
    award amount
  • 5R01CA267479-03R01
    MicroRNA control of tumor-promoting inflammation in colon cancer
    $367K
    award amount
  • 5R21AI175890-02R21
    Therapeutic targeting of PD1 signaling in inflammatory bowel disease
    $255.9K
    award amount
  • 5R21AI174047-02R21
    Development of novel PD1 agonist therapeutic strategies for multiple sclerosis
    $218.2K
    award amount

Award organization

Organizations that administered FY2024 awards listing Murugaiyan Gopal as a PI.

FY2024 award administered by Brigham and Women's Hospital (MA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Brigham and Women's Hospital
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #6928
  5. 2025
    $2M Cumulative Funding
  6. 2025
    R01 Grant Holder